Oceania Cruises announced that it will resume operations with three additional ships, Riviera, Insignia, and Sirena, between October 2021 and January 2022.
Riviera will resume its previously published voyage schedules beginning from Istanbul on Oct. 18, 2021 and sail a series of Mediterranean voyages prior to beginning a winter 2021-2022 series of Caribbean voyages from Miami.
Insignia will resume operations with the Dec. 21, 2021 Panama Canal voyage from Miami prior to embarking on a sold-out 180-day Around the World cruise from Los Angeles to New York.
Sirena will commence sailings starting with the Jan. 22, 2022 Caribbean voyage from Miami to Panama City, Panama.
“This is an exciting day for our guests and team members alike as we begin to prepare another three ships to resume sailing in Europe, the Caribbean, and the eagerly anticipated kickoff of our epic Around the World in 180 Days voyage for 2022,” said Bob Binder, president & CEO of Oceania Cruises, in a press statement.
Voyage itineraries for each ship will continue to be evaluated for port availability and may be adjusted as required closer to the sailing dates. These additional ship restarts follow the April 28 announcement of the line’s Marina resuming cruise operations from Copenhagen beginning on August 29, 2021.
Phased restart dates for Regatta and Nautica will be announced at a later date.
All Oceania Cruises voyages, until further notice, will sail with the requirement that 100 percent of guests and crew be fully vaccinated against COVID-19 to ensure the health and safety of all on board the ships, as well as ashore in the communities visited. The vaccination requirement is the cornerstone of the company’s SailSAFE health and safety program, which was developed with guidance from the company’s team of public health and scientific experts including the Healthy Sail Panel and the SailSAFE Global Health and Wellness Council.
For more information, visit oceaniacruises.com. Don’t miss the 4-1-1 on Oceania Cruises’ new OceaniaNEXT program.
For more cruise news, click here.
